Camille Jauffret
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Camille Jauffret has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Gilles Houvenaeghel
Department of Gynecology, Hopital Européen
6 shared publications - Eric Lambaudie
Department of Surgical Oncology, Institut Paoli Calmettes, Marseille, France
4 shared publications - Guillaume Blache
Institut Paoli Calmettes, Department of Surgical Oncology, Marseille, France
3 shared publications A. Scanvion
CHU, Nantes, France
2 shared publicationsC. Biron
CHU, Nantes, France
2 shared publicationsJ. Coutherut
CHU, Nantes, France
2 shared publications
Latest Publications
- Open Access
- 1 January 2022
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 33 (3)
Posterior pelvic exenteration for ovarian cancer: surgical and oncological outcomes
Houvenaeghel G, et al. J Gynecol Oncol. 2022 Feb;33:e31. https://doi.org/10.3802/jgo.2022.33.e31
- 1 January 2022
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 33 (3)
Open AccessPosterior pelvic exenteration for ovarian cancer: surgical and oncological outcomes
Houvenaeghel G, et al. J Gynecol Oncol. 2022 Feb;33:e31. https://doi.org/10.3802/jgo.2022.33.e31
- Open Access
- 1 January 2021
- Published by Fortune Journals in Journal of Surgery and Research
- Vol. 04 (02) , 218-228
Comparison with 2019 of breast surgery activity and breast cancer prognostic factors in a French cancer center during the first 6 months of the COVID-19 pandemic
Introduction The rapid spread of the COVID-19 pandemic left departments of surgery, especially in oncology unprepared. The diagnostic and therapeutic management of breast cancer in Paoli Calmettes Institute cancer center underwent a major reorganization. Methods This study aimed to describe whether there was a change in the rate of surgical activity and type of tumors treated since the beginning of the outbreak (year 2020 was divided into 3 periods: before March the 17th = P1, between March the 17th and May the 11th = P2, from May the 11th to July 31st = P3) and compared to 2019. Results Over the three periods, a 12.71% decrease in the overall breast cancer surgery activity (n = 967 vs 1062) and a 18.05% decrease in new breast cancer surgery (n = 709 vs 581) was observed. The second period (P2) was the most critical one in both situations. During P2 a higher rate of large tumors, grade SBR 3 and negative endocrine receptor tumors were observed, there was also fewer Luminal A-like histological type diagnosed , during P3 fewer cT0 tumors and finally during both P2 and P3 there was a higher rate of neo-adjuvant chemotherapy. Conclusion This challenging period led to the diagnosis of higher stage and more aggressive histological types of breast cancers subsequently leading to more aggressive treatments.
- 1 January 2021
- Published by Fortune Journals in Journal of Surgery and Research
- Vol. 04 (02) , 218-228
Open AccessComparison with 2019 of breast surgery activity and breast cancer prognostic factors in a French cancer center during the first 6 months of the COVID-19 pandemic
Introduction The rapid spread of the COVID-19 pandemic left departments of surgery, especially in oncology unprepared. The diagnostic and therapeutic management of breast cancer in Paoli Calmettes Institute cancer center underwent a major reorganization. Methods This study aimed to describe whether there was a change in the rate of surgical activity and type of tumors treated since the beginning of the outbreak (year 2020 was divided into 3 periods: before March the 17th = P1, between March the 17th and May the 11th = P2, from May the 11th to July 31st = P3) and compared to 2019. Results Over the three periods, a 12.71% decrease in the overall breast cancer surgery activity (n = 967 vs 1062) and a 18.05% decrease in new breast cancer surgery (n = 709 vs 581) was observed. The second period (P2) was the most critical one in both situations. During P2 a higher rate of large tumors, grade SBR 3 and negative endocrine receptor tumors were observed, there was also fewer Luminal A-like histological type diagnosed , during P3 fewer cT0 tumors and finally during both P2 and P3 there was a higher rate of neo-adjuvant chemotherapy. Conclusion This challenging period led to the diagnosis of higher stage and more aggressive histological types of breast cancers subsequently leading to more aggressive treatments.
- Open Access
- 1 January 2019
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 30 (5) , e74
Transperitoneal para-aortic lymphadenectomy by robot assisted laparoscopy in 10 steps
Heinemann M, et al. J Gynecol Oncol. 2018 Aug;30:e74. https://doi.org/10.3802/jgo.2019.30.e74
- 1 January 2019
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 30 (5) , e74
Open AccessTransperitoneal para-aortic lymphadenectomy by robot assisted laparoscopy in 10 steps
Heinemann M, et al. J Gynecol Oncol. 2018 Aug;30:e74. https://doi.org/10.3802/jgo.2019.30.e74
- Open Access
- 22 January 2018
- Published by Wiley in The Breast Journal
- Vol. 24 (5) , 715-723
Contribution of intraoperative radiotherapy (IORT) for therapeutic de-escalation in early breast cancer: Report of a single institution's experience
The spread of systematic screening and the emergence of oncoplastic techniques allow more breast conservative treatment associating lumpectomy and external beam radiation therapy. In order to furthermore facilitate the patient's treatment, intraoperative radiation therapy (IORT) has been developed. The oncological safety of this technique has been studied, and is considered acceptable. Many questions remain unsolved in regard of the toxicity of this procedure as well as the patient's selection criteria. In this study, we present the first results and complications rate of patients treated by IORT in a single French institution. Between 2012 and 2015, all patients with breast cancer treated in a one-step procedure associating lumpectomy and IORT were retrospectively included in a monocentric cohort. Acute and long-term toxicities were evaluated using CTCAE v4.0 classification. 280 breast cancers were treated using IORT procedure. Additional external beam radiation therapy was requested for 45.7% patients. The acute complications rate was 14.6%, with 5 surgical revisions needed (1.78%). With a median follow up of 911 days, the long-term grade-3 toxicity rate was 1.1%. The only risk factor for local fibrosis was external beam radiation therapy (EBRT) (OR = 1.99; IC95 [1.05–3.81], P = 0.036). Three patients (1.07%) were diagnosed with local recurrence. The results from this cohort confirm the low complication and recurrence rate of IORT procedure. A good selection of patients is necessary in order to lower the EBRT rate and allow therapeutic de-escalation. The classification of tumors into IHC subsets seems a good selection gate. Intraoperative radiation therapy appears to have a low toxicity rate with an acceptable local recurrence risk, and should therefore be considered as an option in the treatment of early breast cancer.
- 22 January 2018
- Published by Wiley in The Breast Journal
- Vol. 24 (5) , 715-723
Open AccessContribution of intraoperative radiotherapy (IORT) for therapeutic de-escalation in early breast cancer: Report of a single institution's experience
The spread of systematic screening and the emergence of oncoplastic techniques allow more breast conservative treatment associating lumpectomy and external beam radiation therapy. In order to furthermore facilitate the patient's treatment, intraoperative radiation therapy (IORT) has been developed. The oncological safety of this technique has been studied, and is considered acceptable. Many questions remain unsolved in regard of the toxicity of this procedure as well as the patient's selection criteria. In this study, we present the first results and complications rate of patients treated by IORT in a single French institution. Between 2012 and 2015, all patients with breast cancer treated in a one-step procedure associating lumpectomy and IORT were retrospectively included in a monocentric cohort. Acute and long-term toxicities were evaluated using CTCAE v4.0 classification. 280 breast cancers were treated using IORT procedure. Additional external beam radiation therapy was requested for 45.7% patients. The acute complications rate was 14.6%, with 5 surgical revisions needed (1.78%). With a median follow up of 911 days, the long-term grade-3 toxicity rate was 1.1%. The only risk factor for local fibrosis was external beam radiation therapy (EBRT) (OR = 1.99; IC95 [1.05–3.81], P = 0.036). Three patients (1.07%) were diagnosed with local recurrence. The results from this cohort confirm the low complication and recurrence rate of IORT procedure. A good selection of patients is necessary in order to lower the EBRT rate and allow therapeutic de-escalation. The classification of tumors into IHC subsets seems a good selection gate. Intraoperative radiation therapy appears to have a low toxicity rate with an acceptable local recurrence risk, and should therefore be considered as an option in the treatment of early breast cancer.
- 1 June 2017
- Published by Elsevier in Medecine Et Maladies Infectieuses
- Vol. 47 (4) , S11-S12
Optimisation du dépistage des maladies infectieuses chez les migrants primo-arrivants : mise en place d’outils d’amélioration du parcours de soins entre une permanence d’accès aux soins de santé (PASS) et un centre fédératif de prévention et de dépistage (CFPD)
- 1 June 2017
- Published by Elsevier in Medecine Et Maladies Infectieuses
- Vol. 47 (4) , S11-S12
Optimisation du dépistage des maladies infectieuses chez les migrants primo-arrivants : mise en place d’outils d’amélioration du parcours de soins entre une permanence d’accès aux soins de santé (PASS) et un centre fédératif de prévention et de dépistage (CFPD)
- 15 October 2016
- Published by Elsevier in Gynécologie Obstétrique & Fertilité
- Vol. 44 (11) , 620-628
Cœlioscopie monotrocart versus micro-cœlioscopie dans la chirurgie annexielle bénigne : résultats d’une étude pilote non randomisée
- 15 October 2016
- Published by Elsevier in Gynécologie Obstétrique & Fertilité
- Vol. 44 (11) , 620-628
Cœlioscopie monotrocart versus micro-cœlioscopie dans la chirurgie annexielle bénigne : résultats d’une étude pilote non randomisée
- 1 June 2016
- Published by Elsevier in Medecine Et Maladies Infectieuses
- Vol. 46 (4) , 101
SP-04 - Vers une amélioration du parcours des usagers entre une pass et un centre de prévention des maladies infectieuses et transmissibles.
- 1 June 2016
- Published by Elsevier in Medecine Et Maladies Infectieuses
- Vol. 46 (4) , 101
SP-04 - Vers une amélioration du parcours des usagers entre une pass et un centre de prévention des maladies infectieuses et transmissibles.